BioNTech develops mRNA cancer immunotherapies, next-generation immunomodulators and targeted therapies in oncology, and vaccines against infectious diseases.

BioNTech SE (/ biːˈɒntɛk / bee-ON-tek; or / baɪˈɒntɛk / bye-ON-tek[3] short for Biopharmaceutical New Technologies) is a German multinational biotechnology company headquartered in Mainz …

Dec 3, 2025 · Biopharmaceutical New Technologies, or BioNTech, is a global, fully integrated next-generation immunotherapy company pioneering novel therapies for cancer, infectious …

Nov 27, 2025 · Pfizer Inc said on Thursday it sold a part of its stake in German drugmaker BioNTech SE , more than five years after both firms formed an alliance that yielded a vaccine …

Jul 31, 2025 · Covid-19 vaccine makers Moderna and BioNTech became household names almost overnight. Moderna and BioNTech have spent their Covid vaccine windfalls differently, …

BioNTech SE (BioNTech) is a biotechnology company that develops immunotherapies for cancer and infectious diseases.

Jun 25, 2025 · The Fact Sheets for Healthcare Providers and for Recipients and Caregivers for Moderna COVID-19 Vaccine and Pfizer-BioNTech COVID-19, which are authorized for …

2 days ago · BioNTech SE Sponsored ADR (NASDAQ:BNTX - Get Free Report) has received a consensus rating of "Moderate Buy" from the fifteen ratings firms that are presently covering …

Get real-time BioNTech SE - ADR (BNTX) stock price, news, financials, community insights, and trading ideas. Join 10 million+ investors and traders tracking markets in real-time on Stocktwits.

BioNTech is a global biopharmaceutical company pioneering novel investigative therapies for cancer and infectious diseases. We are committed to transforming how cancer is treated.